Free Trial
→ Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (From InvestorPlace) (Ad)

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023
Remove Ads

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
4.3815 of 5 stars		$12.29-9.6%N/A-4.45Moderate Buy$37.20
Ultragenyx Pharmaceutical (RARE)
4.4082 of 5 stars		$33.84-6.5%N/A-5.34Moderate Buy$92.79
Sarepta Therapeutics (SRPT)
4.8314 of 5 stars		$61.91-3.0%N/A49.53Moderate Buy$164.05
Pfizer (PFE)
4.981 of 5 stars		$24.53-3.2%7.01%17.39Moderate Buy$31.92
Exelixis (EXEL)
4.5344 of 5 stars		$36.39-1.4%N/A20.56Moderate Buy$37.59
Moderna (MRNA)
4.4005 of 5 stars		$27.16-4.2%N/A-2.93Hold$59.00
United Therapeutics (UTHR)
4.9076 of 5 stars		$306.88-0.5%N/A13.48Moderate Buy$388.25
Biogen (BIIB)
4.8991 of 5 stars		$132.03-3.5%N/A11.80Hold$213.33
Sanofi (SNY)
3.5061 of 5 stars		$54.34-2.0%2.71%21.82Buy$62.50
Eli Lilly and Company (LLY)
4.9478 of 5 stars		$803.70-2.7%0.75%68.63Moderate Buy$1,009.72
Compare These Stocks  Add These Stocks to My Watchlist 

Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

These Are the 3 Stocks Most Likely to SPLIT in 2025
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads